Citadel Advisors’s Microbot Medical MBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-18,039
| Closed | -$29.6K | – | 15125 |
|
|
2023
Q4 | $29.6K | Sell |
18,039
-33,501
| -65% | -$44.6K | ﹤0.01% | 12278 |
|
|
2023
Q3 | $71.6K | Buy |
+51,540
| New | +$112K | ﹤0.01% | 11302 |
|
|
2023
Q2 | – | Sell |
-23,243
| Closed | -$48.3K | – | 14876 |
|
|
2023
Q1 | $48.3K | Buy |
+23,243
| New | +$68.8K | ﹤0.01% | 12193 |
|
|
2022
Q2 | – | Sell |
-14,847
| Closed | -$93K | – | 13611 |
|
|
2022
Q1 | $93K | Buy |
+14,847
| New | +$87K | ﹤0.01% | 12354 |
|
|
2021
Q3 | – | Sell |
-10,194
| Closed | -$81K | – | 14319 |
|
|
2021
Q2 | $81K | Sell |
10,194
-6,299
| -38% | -$47.6K | ﹤0.01% | 13068 |
|
|
2021
Q1 | $140K | Buy |
+16,493
| New | +$142K | ﹤0.01% | 12132 |
|
|
2020
Q2 | – | Sell |
-18,537
| Closed | -$103K | – | 10223 |
|
|
2020
Q1 | $103K | Buy |
+18,537
| New | +$162K | ﹤0.01% | 8616 |
|
|
2019
Q1 | – | Sell |
-13,653
| Closed | -$23K | – | 9633 |
|
|
2018
Q4 | $23K | Buy |
+13,653
| New | +$51.6K | ﹤0.01% | 8693 |
|
|
2018
Q3 | – | Sell |
-4,126
| Closed | -$46K | – | 9512 |
|
|
2018
Q2 | $46K | Sell |
4,126
-5,620
| -58% | -$68.4K | ﹤0.01% | 8452 |
|
|
2018
Q1 | $99K | Buy |
9,746
+5,086
| +109% | +$68.7K | ﹤0.01% | 7713 |
|
|
2017
Q4 | $71K | Buy |
+4,660
| New | +$79.1K | ﹤0.01% | 7533 |
|
|
2017
Q1 | – | Sell |
-740
| Closed | -$68K | – | 7798 |
|
|
2016
Q4 | $68K | Buy |
+740
| New | +$93.5K | ﹤0.01% | 6792 |
|
|
2016
Q2 | – | Sell |
-22
| Closed | -$9K | – | 7154 |
|
|
2016
Q1 | $9K | Sell |
22
-76
| -78% | -$40.1K | ﹤0.01% | 6605 |
|
|
2015
Q4 | $66K | Buy |
98
+82
| +513% | +$60.2K | ﹤0.01% | 7077 |
|
|
2015
Q3 | $11K | Buy |
+16
| New | +$12.2K | ﹤0.01% | 8434 |
|
|
2014
Q3 | – | Sell |
-6
| Closed | -$21K | – | 8284 |
|
|
2014
Q2 | $21K | Sell |
6
-10
| -63% | -$23.1K | ﹤0.01% | 7252 |
|
|
2014
Q1 | $34K | Buy |
16
+9
| +129% | +$21.5K | ﹤0.01% | 7009 |
|
|
2013
Q4 | $13K | Buy |
+7
| New | +$14.8K | ﹤0.01% | 6646 |
|
|
2013
Q3 | – | Sell |
-17
| Closed | -$46K | – | 6808 |
|
|
2013
Q2 | $46K | Buy |
+17
| New | +$47.9K | ﹤0.01% | 5710 |
|
Other funds holding MBOT
VCM
CBU
AA
Citadel Advisors's MBOT Position: Q1 2024 in Review
Citadel Advisors sold out of Microbot Medical (MBOT) in Q1 2024, closing a stake of 18,039 shares — an estimated $29.6K sold.
Citadel Advisors first reported a position in MBOT in Q2 2013 and held it in 19 quarters. The position peaked at $140K in Q1 2021. 33 funds tracked by Wall St. Rank hold MBOT as of Q1 2024.
- Citadel Advisors reported no remaining Microbot Medical position as of Q1 2024 after selling out during the quarter.
- Citadel Advisors sold 18,039 Microbot Medical shares in Q1 2024, an estimated $29.6K.
- Citadel Advisors first reported a position in Microbot Medical in Q2 2013 and held it in 19 quarters.
- Citadel Advisors's Microbot Medical position peaked at $140K in Q1 2021.
- 33 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2024.
Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.